Circulating Neoantigen-Specific T Cells Can Be Prospectively Identified [Immunotherapy]

PD-1 is a biomarker for circulating neoantigen-specific lymphocytes in patients with melanoma.

from Cancer via ola Kala on Inoreader http://ift.tt/1qiynnD
via IFTTT